2024 / 05 / 13
Exhibition and Presentation at
PEGS BOSTON
Ajinomoto Bio-Pharma Services will participate in PEGS BOSTON, on May 13 to 17, 2024.
PEGS BOSTON Summit is the leading biologics event with comprehensive programming covering all aspects of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytics, immunogenicity, and more.
Ajinomoto Bio-Pharma Services will be making luncheon and poster presentations and exhibiting its services and technologies at the conference.
We look forward to your visit.
Event Name | PEGS BOSTON |
---|---|
Dates | May 13 (Mon) – 17 (Fri), 2024 |
Venue | Omni Boston Hotel at the Seaport 450 Summer Street, Boston, MA 02210 |
Exhibition | booth #119 |
Luncheon Presentation
Title and Presenters | “Microbial Production Platform Suitable for Long-Chain Peptides and VHHs” Yumi Nagase, Research Institute for Bioscience Products & Fine Chemicals, Ajinomoto Co., Inc. |
---|---|
Abstract | Ajinomoto Bio-Pharma Services as a fully integrated CDMO offers a broad range of innovative platform technologies and end-to-end solutions for biopharmaceutical development and manufacturing. In this presentation, we will introduce our CDMO capabilities and highlight the CORYNEX® protein and peptide expression platform technology, including its application towards the high-quality manufacture of GLP-1 related peptides, VHHs and ancillary materials to produce pharmaceuticals. |
Date, Time and Venue | May 14(Tue) 14:10 |
Poster Presentation (1)
Session | POSTER SESSION B |
---|---|
Title and Presenters | B006 “Efficient Production of VHHs Containing Non-Canonical Amino Acids by CORYNEX®” Yumi Nagase, Research Institute for Bioscience Products & Fine Chemicals, Ajinomoto Co., Inc. |
Poster Presentation (2)
Session | POSTER SESSION C |
---|---|
Title and Presenters | C009 “AJICAP® Technology Expanding Therapeutic Windows of ADCs and Accelerating Development of Novel Antibody-Based Conjugates” Takumi Hosozawa, Research Institute for Bioscience Products & Fine Chemicals, Ajinomoto Co., Inc. |